Doha, Sept. 15, 2009 Qatar Foundation for Education, Science and Community Development and Weill CornellMedical College in Qatar (WCMC-Q) have unveiled a major initiative to establish a world-class biomedical research program, the first of its kind in the Middle East.
The program aims to form a bio-medical research infrastructure, developing a scientific and technical workforce for the benefit of the region at large. Central to this endeavor is a partnership approach, bringing together institutions that have overlapping missions in medical education, research and healthcare. The program will also support high quality research in the fields of genetic and molecular medicine, women's and children's health, gene therapy, stem cells, and vaccine development.
Specific objectives include: Development of first rate, translational and clinical research projects that establish Qatar as a center of excellence with a focus on improving the health of the population. Development of the bio-medical research infrastructure to include laboratories, compliance and regulatory functions. Creation of a critical mass of research faculty in Qatar and developing a regional scientific and technical workforce. To draw on the strengths of existing and future organizations in the Qatar healthcare sector such as Hamad Medical Corporation (HMC) and Sidra Medical and Research Center. To create a conduit for commercialization of discoveries through the Qatar Science and Technology Park (QSTP)
In five years, approximately 120 people will be engaged in the program, establishing a critical mass, which will give Qatar a sustainable scientific research community. These include principal investigators, post-doctoral fellows, technicians, administrative staff for shared use core facilities, clinical and translational investigators and clinical research support staff.
Vice President for Research at Qatar Foundation Dr. Abdelali Haoudi said: "I am deligh
|Contact: Noura Zreik|
Weill Cornell Medical College--Qatar